Filing Flows › ResMed (RMD) › Capital expenditures
ResMed (RMD) capital expenditures by quarter
ResMed's capital expenditures were $48.7M in Q1 FY27 (first quarter fiscal 2027), -5% from Q4 FY26. Over the last 7 quarters it ranged from $20.8M (Q3 FY25) to $51.1M (Q4 FY26).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $48.7M | -5% | +13% |
| Q4 FY26 | $51.1M | +52% | +67% |
| Q3 FY26 | $33.7M | +18% | +62% |
| Q2 FY26 | $28.5M | -34% | — |
| Q1 FY26 | $43.0M | +40% | — |
| Q4 FY25 | $30.6M | +47% | — |
| Q3 FY25 | $20.8M | — | — |
Q1 FY27 at a glance
ResMed, Q1 FY27: revenue $1.4B (+6% year over year), operating margin 32.0%, net earnings $418M, operating cash flow $422M. The chart follows the revenue to costs, profit and cash.
Questions
What is ResMed's capital expenditures?
ResMed's capital expenditures were $48.7M in Q1 FY27 (first quarter fiscal 2027), -5% from Q4 FY26.
How has ResMed's capital expenditures changed?
Over the last 7 quarters it ranged from $20.8M (Q3 FY25) to $51.1M (Q4 FY26).